Jushi Holdings (JUSHF) Other Non-Current Assets (2021 - 2026)

Jushi Holdings' (JUSHF) quarterly Other Non-Current Assets came in at $2.1 million in Q1 2026, up 10.39% year-on-year from $1.9 million in Q1 2025, and down 92.36% on a QoQ basis from $27.8 million in Q4 2025.

Jushi Holdings (JUSHF) Other Non-Current Assets (2021 - 2026) Analysis & Trends

Jushi Holdings (JUSHF) has 6 years of Other Non-Current Assets data on file, last reported at $2.1 million in Q1 2026.

  • On a quarterly basis, Other Non-Current Assets rose 10.39% year-over-year to $2.1 million in Q1 2026; TTM through Mar 2026 was $2.1 million, a 10.39% increase from a year earlier, with the FY2025 full-year figure at $27.8 million, up 1423.34% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $2.1 million, down from $27.8 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for JUSHF reached as high as $37.3 million in Q2 2023 and fell as low as $625000.0 in Q2 2022.
  • Historically, Other Non-Current Assets has averaged $10.8 million across 5 years, with a median of $2.2 million in 2023.
  • Across the five-year window, Other Non-Current Assets jumped 5863.36% in 2023 and tumbled 94.23% in 2024, its largest moves.
  • Year by year, Other Non-Current Assets stood at $28.2 million in 2022, then tumbled by 92.39% to $2.2 million in 2023, then dropped by 15.12% to $1.8 million in 2024, then jumped by 1423.34% to $27.8 million in 2025, then slumped by 92.36% to $2.1 million in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $2.1 million in Q1 2026, $27.8 million in Q4 2025, and $2.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.79 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 233.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 295.00 Mn
10 Jushi Holdings 81.25 Mn 41.54 Mn 29.88 Mn 2.13 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.13 Mn
Dec 31, 2025 27.80 Mn
Sep 30, 2025 2.23 Mn
Jun 30, 2025 2.03 Mn
Mar 31, 2025 1.93 Mn
Dec 31, 2024 1.83 Mn
Sep 30, 2024 2.15 Mn
Jun 30, 2024 2.15 Mn
Mar 31, 2024 30.32 Mn
Dec 31, 2023 2.15 Mn
Sep 30, 2023 2.15 Mn
Jun 30, 2023 37.27 Mn
Mar 31, 2023 950,000.00
Dec 31, 2022 28.24 Mn
Sep 30, 2022 28.15 Mn
Jun 30, 2022 625,000.00
Dec 31, 2021 525,000.00